Below are the most recent publications written about "Riboflavin" by people in Profiles.
-
Jarrett H, McNulty H, Hughes CF, Pentieva K, Strain JJ, McCann A, McAnena L, Cunningham C, Molloy AM, Flynn A, Hopkins SM, Horigan G, O'Connor C, Walton J, McNulty BA, Gibney MJ, Lamers Y, Ward M. Vitamin B-6 and riboflavin, their metabolic interaction, and relationship with MTHFR genotype in adults aged 18-102 years. Am J Clin Nutr. 2022 12 19; 116(6):1767-1778.
-
Hashemi H, Roberts CJ, Ambr?sio R, Mehravaran S, Hafezi F, Vinciguerra R, Vinciguerra P, Panahi P, Asgari S. Comparative Contralateral Randomized Clinical Trial of Standard (3 mW/cm2) Versus Accelerated (9 mW/cm2) CXL in Patients With Down Syndrome: 3-Year Results. J Refract Surg. 2022 Jun; 38(6):381-388.
-
Davis SA, Bovelle R, Han G, Kwagyan J. Corneal collagen cross-linking for bacterial infectious keratitis. Cochrane Database Syst Rev. 2020 06 17; 6:CD013001.
-
Hashemi H, Mehravaran S, Asgari S. The effect of corneal cross-linking on the anterior and posterior parameters of the cornea: A prospective repeatability study. Rom J Ophthalmol. 2019 Jan-Mar; 63(1):68-74.
-
Asgari S, Hashemi H, Jafarzadehpur E, Mohamadi A, Mehravaran S, Fotouhi A. Low light visual function after accelerated corneal Cross-Linking Protocols: 18 mW/cm2 vs. 9 mW/cm2. Rom J Ophthalmol. 2018 Oct-Dec; 62(4):270-276.
-
Asgari S, Hashemi H, Miraftab M, Shahhoseini S, Jafarzadhpur E, Mehravaran S, Fotouhi A. Photopic, Mesopic, and Scotopic Visual Acuity After 18 mW/cm2 Accelerated Corneal Cross-Linking. Eye Contact Lens. 2018 Sep; 44 Suppl 1:S185-S189.
-
Hashemi H, Asgari S, Mehravaran S, Miraftab M, Ghaffari R, Fotouhi A. Corneal Biomechanics After Accelerated Cross-linking: Comparison Between 18 and 9 mW/cm2 Protocols. J Refract Surg. 2017 Aug 01; 33(8):558-562.
-
Asgari S, Hashemi H, Mohamadi A, Jafarzadehpur E, Miraftab M, Shahhoseini S, Mehravaran S, Fotouhi A. Scotopic contrast sensitivity and glare after accelerated corneal cross-linking. Clin Exp Optom. 2018 Jan; 101(1):52-56.
-
Foley AR, Menezes MP, Pandraud A, Gonzalez MA, Al-Odaib A, Abrams AJ, Sugano K, Yonezawa A, Manzur AY, Burns J, Hughes I, McCullagh BG, Jungbluth H, Lim MJ, Lin JP, Megarbane A, Urtizberea JA, Shah AH, Antony J, Webster R, Broomfield A, Ng J, Mathew AA, O'Byrne JJ, Forman E, Scoto M, Prasad M, O'Brien K, Olpin S, Oppenheim M, Hargreaves I, Land JM, Wang MX, Carpenter K, Horvath R, Straub V, Lek M, Gold W, Farrell MO, Brandner S, Phadke R, Matsubara K, McGarvey ML, Scherer SS, Baxter PS, King MD, Clayton P, Rahman S, Reilly MM, Ouvrier RA, Christodoulou J, Z?chner S, Muntoni F, Houlden H. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain. 2014 Jan; 137(Pt 1):44-56.
-
Cui D, Koder RL, Dutton PL, Miller AF. 15N solid-state NMR as a probe of flavin H-bonding. J Phys Chem B. 2011 Jun 23; 115(24):7788-98.